Oklahoma Administrative Code
Title 450 - Department of Mental Health and Substance Abuse Services
Chapter 70 - Standards and Criteria for Opioid Treatment Programs
Subchapter 4 - Services Support and Enhancement
Part 3 - ORGANIZATIONAL AND FACILITY MANAGEMENT
Section 450:70-4-8.5 - Take-home doses, limits
Universal Citation: OK Admin Code 450:70-4-8.5
Current through Vol. 42, No. 1, September 16, 2024
(a) With the exception of FDA-approved buprenorphine and buprenorphine combination products for opioid use disorder, take-home doses shall be limited, in accordance with 42 CFR § 8.12. Unless requirements at 42 CFR § 8.12 state otherwise, take-home doses shall be limited as follows:
(1) Any person served
in comprehensive treatment may receive their individualized take-home doses as
ordered for days the OTP is closed for business, including one weekend day and
State and Federal holidays, regardless of length of time in
treatment.
(2) During the first
fourteen (14) days of treatment, the take-home supply (beyond that of (1) in
this subsection) is limited to seven (7) days.
(3) Beginning at fifteen (15) days of
treatment, the take-home supply (beyond that of (1) in this subsection) is
limited to fourteen (14) days.
(4)
Beginning at thirty-one (31) days of treatment, the take-home supply (beyond
that of (1) in this subsection) is limited to twenty-eight (28)
days.
(b) Compliance with 450:70-4-8.5 may be determined by:
(1) A review of policies and
procedures,
(2) Treatment records,
and
(3) Other facility
documentation.
Disclaimer: These regulations may not be the most recent version. Oklahoma may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
